BERWYN, Pa., Feb. 11, 2021 /PRNewswire/ -- AMETEK, Inc.
(NYSE: AME) today announced that its Board of Directors has
appointed Karleen Oberton as a new
director of the Company. Ms. Oberton serves as Chief Financial
Officer of Hologic, Inc. (NASDAQ: HOLX), an innovative medical
technology company primarily focused on improving women's health
and well-being through early detection and treatment systems.
"We are pleased to welcome Karleen to AMETEK as a member of our
Board of Directors," commented David A. Zapico, AMETEK
Chairman and Chief Executive Officer. "Karleen is a skilled
business executive with more than 30 years of experience in public
accounting, biotechnology and medical device manufacturing. Her
strong financial acumen along with her proven executive leadership
managing global organizations nicely complements our existing Board
skill set."
Joining Hologic as Vice President and Corporate Controller in
2006, Ms. Oberton has since held roles of increasing responsibility
within the company's finance function. In 2014, she was named
Corporate Vice President and Chief Accounting Officer and in 2018
was elected Chief Financial Officer. Prior to joining Hologic,
Ms. Oberton served as Senior Corporate Controller for
ImmunoGen, a biotechnology company developing targeted anticancer
therapeutics. Earlier in her career, Ms. Oberton held leadership
positions at Ernst & Young and Arthur Andersen.
Ms. Oberton holds a bachelor's degree in Business Administration
from Merrimack College and was an
active Certified Public Accountant for more than 18 years.
Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments
and electromechanical devices with 2020 sales of more than
$4.5 billion. The AMETEK Growth Model
integrates the Four Growth Strategies - Operational Excellence, New
Product Development, Global and Market Expansion, and Strategic
Acquisitions - with a disciplined focus on cash generation and
capital deployment. AMETEK's objective is double-digit percentage
growth in earnings per share over the business cycle and a superior
return on total capital. The common stock of AMETEK is a component
of the S&P 500.
Contact:
AMETEK, Inc.
Kevin Coleman
Vice President, Investor Relations
1100 Cassatt Road
Berwyn, Pennsylvania 19312
kevin.coleman@ametek.com
Phone: 610.889.5247
View original
content:http://www.prnewswire.com/news-releases/ametek-announces-appointment-of-karleen-oberton-to-board-of-directors-301226467.html
SOURCE AMETEK, Inc.